ABT insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Kevin Conroy Director	52,507	$103.99	39%	81K	Sep 23, 2026	Sep 25, 2026

What stands out

Four insiders bought shares: Robert Ford (19K shares, $2.0M), Daniel Starks (20K shares, $2.0M) and Philip Boudreau (2.2K shares, $201K), plus 1 more. These are the first by current officers or directors since Feb 23, 2021.Robert Ford: purchase, Jan 23, 2026 · Daniel Starks: purchase, Apr 27, 2026 · Philip Boudreau: purchase, Apr 23, 2026

Robert Ford sold $46.2M of stock with no disclosed trading plan. The filings don't state a reason.Largest such sale, Aug 25, 2026

Selling picked up in the last 90 days: officers and directors sold 405K shares, against an average of 1.9K per 90 days earlier in the period. Most of it was Robert Ford (399K shares in the last 90 days) and Louis Morrone (5.8K shares in the last 90 days, 8.8% of holdings); 0% of these sales were under disclosed plans.Robert Ford: largest recent sale, Aug 25, 2026 · Louis Morrone: largest recent sale, Aug 11, 2026

Percentages cover 22 of 24 officers and directors. Left out: Robert Ford (most of their shares vested during the period, so a percentage would mislead); Nita Ahuja (held no vested shares at the start). Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stake

Robert Ford

Chairman and CEO, Director

Sold $46.2M (plan status beside the amount). That is 43% of the shares held or received (after tax withholding) during the period†. A share of the starting stake is not shown: most of these shares arrived during the period. Why

$46.2MNo plan disclosed

Louis Morrone

Executive Vice President

11% · $775KNo plan disclosed

Eric Shroff

Senior Vice President

7.2% · $285KNo plan disclosed

Daniel Salvadori

EVP and Group President

0.7% · $102KNo plan disclosed

Mary Moreland

Executive Vice President

0.6% · $71KNo plan disclosed

All 7 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Abbott Laboratories CEO selling stock?

Yes. Robert Ford sold 399K shares ($46.2M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are Abbott Laboratories insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Abbott Laboratories insiders buying?

Yes. 4 officers or directors reported 6 purchases in the past 12 months (Form 4 code P, which includes private purchases).

How much of their stake did Abbott Laboratories insiders sell?

About 0.2% overall. As a group they ended with more shares than they started with. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold7 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Robert Ford Chairman and CEO, Director	$46.2M 399K shares	43%† i † Most of the shares Robert Ford sold arrived during the period, so this is shares sold as a share of the 451K held at the start plus the 501K received, less 30K withheld by the company for taxes.	No plan disclosed
Louis Morrone Executive Vice President	$775K 7K shares	11%	No plan disclosed
Eric Shroff Senior Vice President	$285K 2.3K shares	7.2%	No plan disclosed
Daniel Salvadori EVP and Group President	$102K 885 shares	0.7%	No plan disclosed
Mary Moreland Executive Vice President	$71K 613 shares	0.6%	No plan disclosed
John McCoy Jr. Vice President and Controller	$71K 612 shares	2.9%	No plan disclosed
Elizabeth Cushman EVP, GC and Secretary	$30K 263 shares	1.0%	No plan disclosed

The full ownership picture24 of 24 insiders fully reconciled · 24 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Daniel Starks

Includes unvested RSUs, amount not disclosed.

Director

6.73M

6.75M

no sales

Vesting, gifts, unvested awards and holding lines for Daniel Starks

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	6,728,817	6,751,103
Alynne Starks 2012 Irrevocable Trust	Common shares without par value	258	258

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,277	$107.14	Apr 25, 2034	$13K
4,516	$128.40	Apr 24, 2035	$0
7,105	$91.86	Apr 23, 2036	$126K

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Robert Ford

Chairman and CEO, Director

451K

−399K

523K

not meaningful

Vesting, gifts, unvested awards and holding lines for Robert Ford

+399Kshares vested or exercised

0gifted (net of own trusts)

−30Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	253,305	306,461
Ford Family Trust	Common shares without par value	197,403	216,203

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
264,293	$116.98	Feb 20, 2034	$0
241,706	$135.42	Feb 24, 2035	$0
344,066	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Daniel Salvadori

EVP and Group President

134K

−885

146K

+9.4%

Vesting, gifts, unvested awards and holding lines for Daniel Salvadori

0shares vested or exercised

−1.5Kgifted (net of own trusts)

−6.6Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	133,769	146,377

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
58,898	$116.98	Feb 20, 2034	$0
61,580	$135.42	Feb 24, 2035	$0
89,226	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Kevin Conroy

Minor difference of 2 shares. Difference is under 0.5% of holdings. Started reporting during the period; starting holdings are from the Form 3.

Director

131K

82K

no sales

Vesting, gifts, unvested awards and holding lines for Kevin Conroy

0shares vested or exercised

0gifted (net of own trusts)

−53Kwithheld by the company for taxes

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	131,451	81,230
Direct	Stock Equivalent Units	0	551

Reconciliation: minor difference of 2 shares. Difference is under 0.5% of holdings.

Mary Moreland

Minor difference of 222 shares. Difference is under 0.5% of holdings.

Executive Vice President

107K

−613

121K

+13%

Vesting, gifts, unvested awards and holding lines for Mary Moreland

0shares vested or exercised

0gifted (net of own trusts)

−4.6Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	95,583	104,291
Profit Sharing Trust	Common shares without par value	11,623	17,159

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
39,734	$116.98	Feb 20, 2034	$0
39,896	$135.42	Feb 24, 2035	$0
57,512	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Reconciliation: minor difference of 222 shares. Difference is under 0.5% of holdings.

Lisa Earnhardt

Includes unvested RSUs, amount not disclosed.

EVP and Group President

72K

90K

no sales

Vesting, gifts, unvested awards and holding lines for Lisa Earnhardt

0shares vested or exercised

0gifted (net of own trusts)

−8.6Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	71,928	90,407

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
64,787	$116.98	Feb 20, 2034	$0
69,977	$135.42	Feb 24, 2035	$0
111,533	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Louis Morrone

Executive Vice President

67K

−7K

71K

+6.2%

Vesting, gifts, unvested awards and holding lines for Louis Morrone

0shares vested or exercised

0gifted (net of own trusts)

−4.3Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	66,609	70,724
Profit Sharing Trust	Common shares without par value	12	0

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
46,257	$116.98	Feb 20, 2034	$0
38,108	$135.42	Feb 24, 2035	$0
63,561	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Christopher Scoggins

Started reporting during the period; starting holdings are from the Form 3. New Form 3 filed 2025-12-19; earlier filings set aside.

Executive Vice President

64K

77K

no sales

Vesting, gifts, unvested awards and holding lines for Christopher Scoggins

0shares vested or exercised

0gifted (net of own trusts)

−5Kwithheld by the company for taxes

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.
New Form 3 filed 2025-12-19; earlier filings set aside.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	63,621	77,126

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
51,557	$75.90	Feb 21, 2029	$1.7M
43,388	$79.98	Mar 31, 2029	$1.3M
68,578	$87.72	Feb 20, 2030	$1.5M
63,991	$124.04	Feb 18, 2031	$0
48,852	$117.58	Feb 17, 2032	$0
37,483	$106.24	Feb 16, 2033	$124K
31,721	$116.98	Feb 20, 2034	$0
45,730	$135.42	Feb 24, 2035	$0
76,273	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Robert Alpern

Minor difference of 106 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

Director

51K

no sales

Vesting, gifts, unvested awards and holding lines for Robert Alpern

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	40,798	40,798
Direct	Stock Equivalent Units	10,300	10,544

Reconciliation: minor difference of 106 shares. Difference is under 0.5% of holdings.

Philip Boudreau

Minor difference of 60 shares. Difference is under 0.5% of holdings.

EVP and CFO

51K

82K

no sales

Vesting, gifts, unvested awards and holding lines for Philip Boudreau

0shares vested or exercised

0gifted (net of own trusts)

−7.8Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	50,616	70,784
Profit Sharing Trust	Common shares without par value	363	9,332
Spouse	Common shares without par value	0	2,200

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
86,519	$116.98	Feb 20, 2034	$0
83,783	$135.42	Feb 24, 2035	$0
115,413	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Reconciliation: minor difference of 60 shares. Difference is under 0.5% of holdings.

Nancy McKinstry

Includes unvested RSUs, amount not disclosed.

Director

39K

41K

no sales

Vesting, gifts, unvested awards and holding lines for Nancy McKinstry

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	38,724	41,010

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,850	$107.14	Apr 25, 2034	$16K
1,465	$128.40	Apr 24, 2035	$0
2,305	$91.86	Apr 23, 2036	$41K

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Jacob Orville

Started reporting during the period; starting holdings are from the Form 3.

Senior Vice President

37K

50K

no sales

Vesting, gifts, unvested awards and holding lines for Jacob Orville

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	37,238	50,493

Sally Blount

Includes unvested RSUs, amount not disclosed.

Director

34K

36K

no sales

Vesting, gifts, unvested awards and holding lines for Sally Blount

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	34,058	36,344

Eric Shroff

Senior Vice President

32K

−2.3K

39K

+23%

Vesting, gifts, unvested awards and holding lines for Eric Shroff

0shares vested or exercised

0gifted (net of own trusts)

−1.4Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	31,970	39,164

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
26,971	$75.90	Feb 21, 2029	$907K
29,020	$87.72	Feb 20, 2030	$633K
20,045	$124.04	Feb 18, 2031	$0
20,404	$117.58	Feb 17, 2032	$0
13,056	$106.24	Feb 16, 2033	$43K
13,250	$116.98	Feb 20, 2034	$0
27,227	$135.42	Feb 24, 2035	$0
44,821	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

John Stratton

Minor difference of 312 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

32K

38K

no sales

Vesting, gifts, unvested awards and holding lines for John Stratton

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	19,033	23,319
Direct	Stock Equivalent Units	12,663	14,499

Reconciliation: minor difference of 312 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Elizabeth Cushman

EVP, GC and Secretary

25K

−263

38K

+51%

Vesting, gifts, unvested awards and holding lines for Elizabeth Cushman

0shares vested or exercised

0gifted (net of own trusts)

−2Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	25,226	38,013

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,439	$106.24	Feb 16, 2033	$34K
9,717	$116.98	Feb 20, 2034	$0
20,606	$135.42	Feb 24, 2035	$0
14,680	$133.90	Jun 26, 2035	$0
61,964	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

John McCoy Jr.

Minor difference of 2 shares. Difference is under 0.5% of holdings.

Vice President and Controller

21K

−612

25K

+17%

Vesting, gifts, unvested awards and holding lines for John McCoy Jr.

0shares vested or exercised

0gifted (net of own trusts)

−1.2Kwithheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	20,982	24,549
Profit Sharing Trust	Common shares without par value	57	59

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,563	$116.98	Feb 20, 2034	$0
15,040	$135.42	Feb 24, 2035	$0
22,151	$114.60	Feb 23, 2036	$0

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Reconciliation: minor difference of 2 shares. Difference is under 0.5% of holdings.

Michelle Kumbier

Includes unvested RSUs, amount not disclosed.

Director

16K

18K

no sales

Vesting, gifts, unvested awards and holding lines for Michelle Kumbier

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	15,714	18,000

Michael Roman

Minor difference of 145 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

14K

18K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Roman

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	8,478	10,764
Direct	Stock Equivalent Units	5,556	7,166

Reconciliation: minor difference of 145 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Patricia Gonzalez

Minor difference of 129 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

12K

16K

no sales

Vesting, gifts, unvested awards and holding lines for Patricia Gonzalez

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	6,919	9,205
Direct	Stock Equivalent Units	4,922	6,331

Reconciliation: minor difference of 129 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Darren McDew

Includes unvested RSUs, amount not disclosed.

Director

10K

13K

no sales

Vesting, gifts, unvested awards and holding lines for Darren McDew

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	10,392	12,678

Claire Babineaux-Fontenot

Includes unvested RSUs, amount not disclosed.

Director

5.3K

7.6K

no sales

Vesting, gifts, unvested awards and holding lines for Claire Babineaux-Fontenot

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	5,317	7,603

Michael O'Grady

Includes unvested RSUs, amount not disclosed.

Director

5.3K

7.6K

no sales

Vesting, gifts, unvested awards and holding lines for Michael O'Grady

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common shares without par value	5,317	7,603

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,404	$107.14	Apr 25, 2034	$11K
3,769	$128.40	Apr 24, 2035	$0
5,929	$91.86	Apr 23, 2036	$105K

Estimate: options held × ($109.54 − strike price), using the most recent insider trade price on Form 4 (Sep 2, 2026), not a market close.

Nita Ahuja

Minor difference of 4 shares. Difference is under 0.5% of holdings.

Director

3.1K

no sales

Vesting, gifts, unvested awards and holding lines for Nita Ahuja

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common shares without par value	0	2,286
Direct	Stock Equivalent Units	0	771

Reconciliation: minor difference of 4 shares. Difference is under 0.5% of holdings.

24 of 24 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (15 exactly, 9 with a minor or footnoted difference). Percentages cover 22 of 24 officers and directors. Left out: Robert Ford (most of their shares vested during the period, so a percentage would mislead); Nita Ahuja (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$47.5M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $47.5M across 410,494 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $47.5M

Sales with no 10b5-1 plan and no tax reference in the filing. $46.2M of it is Robert Ford. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Robert Ford, Aug 25, 2026

Taxes

124,331 shares ($13.8M) were withheld by the company for taxes, which isn't a market sale.

Purchases · 4 buyers (6 trades)

4 officers and directors bought shares in this period, in 6 trades(Form 4 code P). Across all their filings on record there are 78 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Robert Ford Chairman and CEO, Director	399K	$46.2M	0%	97%	Aug 25, 2026 to Aug 25, 2026
Louis Morrone Executive Vice President	7K	$775K	0%	2%	Mar 2, 2026 to Aug 11, 2026
Eric Shroff Senior Vice President	2.3K	$285K	0%	0.6%	Nov 25, 2025 to Mar 2, 2026
Daniel Salvadori EVP and Group President	885	$102K	0%	0.2%	Mar 2, 2026 to Mar 2, 2026
Mary Moreland Executive Vice President	613	$71K	0%	0.1%	Mar 2, 2026 to Mar 2, 2026
John McCoy Jr. Vice President and Controller	612	$71K	0%	0.1%	Mar 2, 2026 to Sep 2, 2026
Elizabeth Cushman EVP, GC and Secretary	263	$30K	0%	0.1%	Mar 2, 2026 to Mar 2, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$203K	$0	$0	$203K
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$485K	$0	$0	$485K
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$46.8M	$0	$0	$46.8M
Sep 2026	$3K	$0	$0	$3K
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 7 insiders sold; the average is 15 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	410K	7	$47.5M
Oct 9, 2025 1 year earlier	763K	11	$97.5M
Oct 9, 2024 2 years earlier	299K	10	$33.1M
Oct 10, 2023 3 years earlier	205K	16	$22.0M
Oct 10, 2022 4 years earlier	697K	20	$86.3M
Oct 10, 2021 5 years earlier	712K	19	$86.7M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertaintyEvery officer and director reconciles

Every officer and director reconciles for this period.

Kevin Conroy: minor difference of 2 shares. Difference is under 0.5% of holdings.

Mary Moreland: minor difference of 222 shares. Difference is under 0.5% of holdings.

Robert Alpern: minor difference of 106 shares. Difference is under 0.5% of holdings.

Philip Boudreau: minor difference of 60 shares. Difference is under 0.5% of holdings.

John Stratton: minor difference of 312 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

John McCoy Jr.: minor difference of 2 shares. Difference is under 0.5% of holdings.

Michael Roman: minor difference of 145 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Patricia Gonzalez: minor difference of 129 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Nita Ahuja: minor difference of 4 shares. Difference is under 0.5% of holdings.

Inferred rename: "self for son" is treated as the same holder as "son", because the old name was never reported again and the new one opened with the same balance (1,941 shares). Old name, new name

Inferred rename: "wife for son" is treated as the same holder as "son", because the old name was never reported again and the new one opened with the same balance (4,755 shares). Old name, new name

Inferred rename: "Spouse" is treated as the same holder as "Trust", because the old name was never reported again and the new one opened with the same balance (72 shares). Old name, new name

Inferred rename: "Profit Sharing Trust (US)" is treated as the same holder as "Profit Sharing Trust (U.S.)", because the old name was never reported again and the new one opened with the same balance (627 shares). Old name, new name

Inferred typo: the share class "Common share without par value" is treated as the same class as "Common shares without par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Thomas Freyman, 76,000 shares): old title, new title

Inferred typo: the share class "Common shares without par valuef" is treated as the same class as "Common shares without par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Miles White, 3,408,873 shares): old title, new title

Inferred typo: the share class "Common shares wihtout par value" is treated as the same class as "Common shares without par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Brian Blaser, 50 shares): old title, new title

Inferred typo: the share class "Commons shares without par value" is treated as the same class as "Common shares without par value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Michael Dale, 37,697 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology2,566 filings from SEC EDGAR, and how we read them

All 2,566 Forms 3, 4 and 5 filed for Abbott Laboratories (SEC CIK 1800) from Aug 13, 1998 to Oct 2, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 18 filings were left out because Abbott Laboratories filed them as an owner of another company's stock. 4 older filings exist only on paper and could not be read.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (85)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Hubert Allen	Mar 4, 2025	191,899 shares, last reported balance as of Feb 28, 2025
Andrea Wainer	Mar 4, 2025	74,381 shares, last reported balance as of Mar 3, 2025
Robert Funck Jr.	May 14, 2024	287,260 shares, last reported balance as of May 10, 2024
John Capek	Mar 2, 2023	339,443 shares, last reported balance as of Feb 28, 2023
Jared Watkin	Mar 2, 2023	72,018 shares, last reported balance as of Mar 1, 2023
Joseph Manning	Mar 2, 2023	62,323 shares, last reported balance as of Mar 1, 2023
Michael Pederson	Mar 2, 2023	63,231 shares, last reported balance as of Feb 28, 2023
Alejandro Wellisch	Mar 2, 2023	46,752 shares, last reported balance as of Feb 28, 2023
Sammy Karam	Mar 2, 2023	38,092 shares, last reported balance as of Feb 28, 2023
Randel Woodgrift	Mar 2, 2023	55,698 shares, last reported balance as of Mar 1, 2023
John Ginascol	Mar 2, 2023	118,380 shares, last reported balance as of Mar 1, 2023
Michael Dale	Mar 2, 2023	45,133 shares, last reported balance as of Mar 1, 2023
Gregory Ahlberg	Mar 2, 2023	49,437 shares, last reported balance as of Mar 1, 2023
Christopher Calamari	Mar 2, 2023	63,118 shares, last reported balance as of Feb 28, 2023
Julie Tyler	Mar 2, 2023	48,675 shares, last reported balance as of Mar 1, 2023
Fernando Mateus	Mar 2, 2023	22,857 shares, last reported balance as of Feb 28, 2023
Glenn Tilton	May 3, 2022	82,497 shares, last reported balance as of Apr 29, 2022
William Osborn	May 3, 2022	125,561 shares, last reported balance as of Apr 29, 2022
Miles White	Dec 8, 2021	3,148,611 shares, last reported balance as of Nov 12, 2021
Andrew Lane	Nov 17, 2021	77,630 shares, last reported balance as of Nov 15, 2021
Roger Bird	Apr 29, 2021	51,083 shares, last reported balance as of Apr 27, 2021
Roxanne Austin	Apr 27, 2021	41,542 shares, last reported balance as of Apr 23, 2021
Charles Brynelsen	Mar 2, 2021	43,550 shares, last reported balance as of Mar 1, 2021
Phebe Novakovic	Dec 8, 2020	41,004 shares, last reported balance as of Dec 4, 2020
Edward Liddy	Apr 28, 2020	50,240 shares, last reported balance as of Apr 24, 2020
Jaime Contreras	Apr 23, 2020	253,149 shares, last reported balance as of Apr 21, 2020
Brian Yoor	Mar 3, 2020	116,347 shares, last reported balance as of Feb 28, 2020
Brian Blaser	May 24, 2019	130,745 shares, last reported balance as of May 23, 2019
Samuel Scott III	Apr 30, 2019	45,655 shares, last reported balance as of Apr 26, 2019
Stephen Fussell	Apr 24, 2019	171,686 shares, last reported balance as of Apr 23, 2019
Sharon Bracken	Apr 2, 2019	6,696 shares, last reported balance as of Mar 31, 2019
Sean Shrimpton	Jan 3, 2019	16,165 shares, last reported balance as of Dec 31, 2018
Eric Fain	Sep 29, 2017	493,961 shares, last reported balance as of Jul 21, 2017
Michael Rousseau	Jul 11, 2017	629,294 shares, last reported balance as of Jul 7, 2017
Heather Mason	Jul 5, 2017	129,064 shares, last reported balance as of Jul 1, 2017
Deepak Nath	May 2, 2017	51,241 shares, last reported balance as of Apr 28, 2017
Michael Warmuth	Mar 2, 2017	95,921 shares, last reported balance as of Mar 1, 2017
Thomas Freyman	Jul 29, 2016	559,829 shares, last reported balance as of Jul 29, 2016
Jean-Yves Pavee	Jul 6, 2016	51,873 shares, last reported balance as of Jul 1, 2016
James Farrell	May 3, 2016	28,557 shares, last reported balance as of Apr 29, 2016
Richard Ashley	Mar 2, 2016	354,517 shares, last reported balance as of Feb 29, 2016
Thomas Frinzi	Feb 23, 2016	31,921 shares, last reported balance as of Feb 19, 2016
Charles Foltz	Apr 2, 2015	93,333 shares, last reported balance as of Apr 1, 2015
Scott White	Mar 27, 2015	95,719 shares, last reported balance as of Mar 26, 2015
Katherine Doyle	Mar 13, 2015	43,327 shares, last reported balance as of May 23, 2014
John Landgraf	Mar 3, 2015	128,106 shares, last reported balance as of Feb 27, 2015
Murthy Simhambhatla	Mar 3, 2015	57,575 shares, last reported balance as of Feb 27, 2015
Georges DeVos	Mar 3, 2015	12,129 shares, last reported balance as of Feb 27, 2015
David Forrest	Sep 19, 2013	42,013 shares, last reported balance as of Sep 17, 2013
Greg Linder	Mar 1, 2013	141,609 shares, last reported balance as of Feb 28, 2013
Paul Magill	Feb 20, 2013	33,000 shares, last reported balance as of Feb 15, 2013
James Mazzo	Feb 4, 2013	79,747 shares, last reported balance as of Dec 7, 2012
Richard Gonzalez	Dec 21, 2012	185,575 shares, last reported balance as of Apr 6, 2012
Laura Schumacher	Dec 13, 2012	179,338 shares, last reported balance as of Dec 11, 2012
Carlos Alban	Dec 4, 2012	136,770 shares, last reported balance as of Dec 1, 2012
Laurance Fuller	Apr 3, 2012	41,569 shares, last reported balance as of Mar 31, 2012
Robert Hance	Mar 2, 2012	171,871 shares, last reported balance as of Mar 1, 2012
Edward Michael	Mar 2, 2012	229,617 shares, last reported balance as of Feb 29, 2012
Corlis Murray	Feb 16, 2012	44,328 shares, last reported balance as of Feb 14, 2012
Mary Szela	Dec 16, 2011	119,422 shares, last reported balance as of Dec 14, 2011
David Owen	May 3, 2011	16,175 shares, last reported balance as of Apr 29, 2011
Donald Patton Jr.	Mar 2, 2011	123,771 shares, last reported balance as of Feb 28, 2011
Roy Roberts	Feb 1, 2011	25,123 shares, last reported balance as of Jan 31, 2011
William Daley	Jan 4, 2011	28,496 shares, last reported balance as of Dec 31, 2010
Holger Liepmann	Dec 30, 2010	184,109 shares, last reported balance as of Dec 23, 2010
William Smithburg	Nov 12, 2010	70,526 shares, last reported balance as of Nov 9, 2010
Thomas Chen	May 27, 2010	156,697 shares, last reported balance as of May 25, 2010
Olivier Bohuon	Mar 2, 2010	110,509 shares, last reported balance as of Feb 26, 2010
Ann Reynolds	Apr 28, 2009	58,849 shares, last reported balance as of Apr 24, 2009
Boone Powell Jr.	Apr 2, 2009	56,633 shares, last reported balance as of Mar 31, 2009
James Tyree	Mar 3, 2009	133,375 shares, last reported balance as of Feb 27, 2009
William Dempsey	Aug 9, 2007	248,371 shares, last reported balance as of Aug 8, 2007
Joseph Nemmers	Feb 28, 2007	132,555 shares, last reported balance as of Feb 26, 2007
Gary McCullough	Feb 20, 2007	93,329 shares, last reported balance as of Feb 20, 2007
Jeffrey Binder	Feb 20, 2007	44,661 shares, last reported balance as of Feb 20, 2007
Edward Fiorentino	Feb 1, 2007	118,142 shares, last reported balance as of Jan 30, 2007
John Walter	Sep 26, 2006	36,980 shares, last reported balance as of Sep 22, 2006
Jack Greenberg	May 2, 2006	10,860 shares, last reported balance as of Apr 28, 2006
Jeffrey Leiden	Mar 28, 2006	210,036 shares, last reported balance as of Mar 24, 2006
Barry Rand	Jan 4, 2006	26,236 shares, last reported balance as of Dec 31, 2005
Thomas Wascoe	Feb 23, 2005	78,295 shares, last reported balance as of Oct 28, 2004
Jose De Lasa	Feb 23, 2005	115,302 shares, last reported balance as of Feb 14, 2005
Christopher Begley	May 4, 2004	494,626 shares, last reported balance as of Apr 30, 2004
Guillermo Herrera	Feb 24, 2004	131,601 shares, last reported balance as of Feb 20, 2004
Lance Wyatt	Feb 24, 2004	181,111 shares, last reported balance as of Feb 20, 2004

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Abbott Laboratories insiders sold $47.5M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Abbott Laboratories CEO selling stock?

Why are Abbott Laboratories insiders selling?

Are any Abbott Laboratories insiders buying?

How much of their stake did Abbott Laboratories insiders sell?

The evidence

No plan disclosed · $47.5M

Taxes

Purchases · 4 buyers (6 trades)

Sales by month